Rise in Prevalence of Diabetes Drives Negative Pressure Wound Therapy Devices Market Growth

Negative pressure wound therapy (NPWT) is essential to the management of diabetes, as it assists in the treatment of diabetic wounds. Patients affected by diabetes are more likely to develop chronic wounds such as foot ulcers and frequently have delayed wound healing. By improving blood flow, decreasing edema, and eliminating surplus exudate, NPWT facilitates wound healing by fostering an atmosphere conducive to tissue regeneration. In diabetic patients, it can be a useful adjunctive therapy for controlling diabetic foot ulcers and avoiding complications related to delayed wound healing. Sedentary lifestyle, high-calorie diets, and increased stress contribute to obesity and insulin resistance, two key risk factors for Type 2 diabetes. Additionally, as the world’s population ages, the prevalence of diabetes increases. Aging is associated with a decline in insulin sensitivity, making older people more likely to develop diabetes.
Thus, the increasing number of patients affected by diabetes and rising geriatric population fuel the negative pressure wound therapy devices market growth. According to the World Health Organization (WHO), 422 million people across the world have diabetes, with the majority residing in low- and middle-income countries.

Market Opportunity
Opportunities in Emerging Markets
Chronic wounds are more common in developing nations due to the rising burden of chronic diseases such as diabetes and vascular conditions. Advanced wound care technologies are witnessing a rise in demand as developing countries become more aware of healthcare issues. NPWT devices can treat patients affected by chronic wounds due to their efficacy. Developing nations are investing in upgrading their healthcare systems, opening doors for cutting-edge medical technology such as NPWT devices. People in developing nations look for more advanced wound care options as disposable income rises, and medical professionals might be willing to spend more money on NPWT devices to improve patient care.
Thus, the rising demand for NPWT devices in developing countries would provide lucrative opportunities for the negative pressure wound therapy devices market in the coming years.

Negative Pressure Wound Therapy Devices Market: Geographic Overview

Geographically, the negative pressure wound therapy devices market report is segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America held the largest market share. The presence of key players with a significant product portfolio and early adoption of technologically advanced products drive the region’s market growth. In March 2020, global medical technology company Smith+Nephew announced the introduction of a new PICO 14 Single Use Negative Pressure Wound Therapy System (sNPWT) in the US.
Asia Pacific is expected to register the highest CAGR in the negative pressure wound therapy devices market during 2022–2030. A growing need for advanced wound care solutions such as NPWT devices in Asia Pacific due to the rising prevalence of diabetes, vascular disorders, and other chronic diseases that can cause chronic wounds propels the market growth in the region. According to World Health Organization (WHO), an estimated 77 million Indians over the age of 18 have type 2 diabetes, and another 25 million are prediabetics, meaning they have a higher chance of getting the disease shortly. Over 50% of people do not know they have diabetes, which can cause health issues if it is not identified and treated promptly.

Negative Pressure Wound Therapy Devices Industry Developments:
As per company press releases, a few strategic developments by leading players operating in the negative pressure wound therapy devices market are listed below:
• In January 2024, Lion Street Medical, LLC announced the acquisition of Pensar Medical, LLC, a well-known medical device company specializing in wound care. The acquisition, completed in October 2023, provides new leadership to the trusted Pensar Medical and WoundPro brands.
• In June 2023, InfuSystem Holdings Inc. signed a national distribution agreement with Genadyne Biotechnologies Inc. for its NPWT systems and supplies. This agreement allows InfuSystem to offer Genadyne’s entire line of wound care products.
• In May 2023, global medical technology leader Smith+Nephew announced that Vizient, Inc., the country’s largest member-driven healthcare performance improvement company, has awarded an Innovative Technology contract for its PICO Single Use Negative Pressure Wound Therapy Systems. The contract represents special attributes to Vizient members that may enhance the healthcare sector. It was granted based on the PICO Single Use Negative Pressure Wound Therapy Systems recommendation by hospital specialists who sit on one of Vizient’s member-led councils.

Negative Pressure Wound Therapy Devices Market: Competitive Landscape
The negative pressure wound therapy devices market analysis is carried out by identifying and evaluating key players in the market across different regions. 3M; Smith+Nephew; DeRoyal Industries, Inc.; Nexa Medical Limited; Lion Street Medical, LLC (Pensar Medical LLC); ConvaTec Inc.; Cardinal Health, Inc.; Mölnlycke Health Care AB; PAUL HARTMANN; and Medela AG are among the prominent players profiled in the market report. These companies focus on introducing new technologies, upgrading existing products, and undertaking geographic expansions to be able to address the globally increasing consumer demand.